Emplgin Met Extended-Release Tablet 25/1000 mg (Empagliflozin, Metformin Hydrochloride)

Adult dose

The dosage of this medication in anti-diabetic therapy should be determined within the range of the maximum recommended daily dosage of empagliflozin 25 mg and extended-release metformin hydrochloride 2000 mg for each patient, considering their current treatment, efficacy, and tolerability. This medication is to be taken once daily during the evening with meals to reduce the gastrointestinal side effects caused by metformin. This medication is 10/1000 mg,

This medication is used for the treatment of diabetes and contains two components that assist in blood sugar control. Care should be taken while taking this medication as there is a risk of a rare side effect called severe lactic acidosis. Lactic acidosis occurs when there is an excessive build-up of lactic acid in the body, which can lead to severe conditions and can sometimes be life-threatening. When used with other diabetes medications, hypoglycemia may occur, so blood sugar levels should be monitored frequently, and medication dosage should be adjusted as necessary in consultation with a physician. This medication should not be administered to patients with severely impaired kidney function, acute renal issues, severe infections, heart failure, or certain specific health conditions. Before and after tests involving iodine contrast agents, this medication should be temporarily discontinued due to the risk of deteriorated kidney function and lactic acidosis, and should only be resumed once kidney function has returned to normal. It is safer for pregnant or breastfeeding women to avoid using this medication; if breastfeeding, nursing should be halted. This medication may lead to fluid volume loss, so caution is advised if there are symptoms of dehydration or risk of fluid loss. Additionally, this medication may increase the risk of genital infections and urinary tract infections, so any signs of infection should prompt immediate consultation with a physician. As it may decrease vitamin B12 levels, blood tests to monitor vitamin B12 levels are recommended for individuals on this medication for long periods. Elderly patients or those with poor kidney function should have their kidney function thoroughly evaluated before starting this medication and should regularly monitor their kidney function. Alcohol consumption should be avoided while taking this medication, as alcohol can increase the risk of lactic acidosis. If symptoms such as vomiting, diarrhea, severe muscle pain, or breathing difficulties occur, immediate medical assistance should be sought, as these symptoms may indicate lactic acidosis or ketoacidosis. The tablet should be swallowed whole and not chewed, crushed, or divided, and it is normal for the tablet shell to pass in stool. This medication may interact with other drugs, so it is essential to inform your physician or pharmacist about any other medications you are taking. In cases of overdose, there is a risk of hypoglycemia or lactic acidosis, so medication dosage should not be changed without a doctor's direction, and immediate hospital visit is required in case of an overdose.

Serious side effects

• Hives
• angioedema
• perineal necrosis
• ketoacidosis
• lactic acidosis
• acute pyelonephritis
• urosepsis
• myocardial infarction
• cerebral infarction
• hepatitis

Mild side effects

• Hypoglycemia
• urinary tract infections
• genital infections
• increased urination
• nausea
• vomiting
• diarrhea
• abdominal pain
• loss of appetite
• constipation

This medication should be stored in a tightly sealed container to protect it from air and moisture. The appropriate storage temperature is room temperature between 1 to 30 degrees Celsius. Avoid storing it in excessively hot or cold areas.

Appearance

Light yellow, oval-shaped, double-convex extended-release film-coated tablet

Package unit

30 tablets/bottle